QuidelOrtho Corporation reported $2.67B of revenue over the trailing twelve months, −2.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.67B (to Q2 2026). Net income: −$1.05B, trailing twelve months to Q2 2026. Free cash flow: −$211M, trailing twelve months to Q2 2026. Operating margin: −30%, trailing twelve months to Q2 2026.

QDELQuidelOrtho Corporation

Healthcare

$12.41-55% 1Y

$12.41

$9.9652 weeks$35.38

QDEL as reported

QuidelOrtho Corporation reported $2.67B of revenue over the trailing twelve months, −2.5% on the year before. 11 reported series are charted on this page, each one as filed.

$2.67B

Revenue, trailing twelve months · to Q2 2026 · −2.5% against the twelve months before

Net income: −$1.05B
Net income · +125% year on year · trailing twelve months to Q2 2026
Free cash flow: −$211M
Free cash flow · −1725% year on year · trailing twelve months to Q2 2026
Operating margin: −30%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for QDEL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.67B	−2.5%	Q2 2026
Net income	−$1.05B	+125%	Q2 2026
EPS	−$15.39	+124%	Q2 2026
Gross margin	45%	n/a	Q2 2026
Operating margin	−30%	n/a	Q2 2026
Net margin	−38%	n/a	Q2 2026
ROE	−60%	n/a	Q2 2026
ROA	−20%	n/a	Q2 2026
ROIC	−16%	n/a	Q2 2026
Free cash flow	−$211M	−1725%	Q2 2026
P/E	20.0	n/a	Q1 2023 · 13 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.